| ²é¿´: 399 | »Ø¸´: 1 | ||
wqssfj1Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
ÇóÖú·Ò룡£¡£¡
|
| If any abnormalities are found after the Baseline visit and study drug administration, evaluate as potential adverse experience (AE), defined as an unfavorable and unintended change in the structure(signs), function (symptoms) or chemistry (laboratory data) of the body from baseline. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ085600Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á Ò»Ö¾Ô¸Î÷ÄϽ»Í¨´óѧ085701»·¾³¹¤³Ì 282·Ö
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
²ÄÁÏר˶283Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
£¨µ÷¼Á£©Ò»Ö¾Ô¸±¨¿¼¹þ¶û±õ¹¤Òµ´óѧ0857×ÊÔ´Óë»·¾³×¨Òµ378·Ö¿¼Éú
ÒѾÓÐ3È˻ظ´
±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
yangxiuhuaya
ͳæ (СÓÐÃûÆø)
- ·ÒëEPI: 8
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 175.7
- Ìû×Ó: 68
- ÔÚÏß: 11.4Сʱ
- ³æºÅ: 1545573
- ×¢²á: 2011-12-21
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÉúÀíÓëÉúÎﻯѧ

2Â¥2012-06-29 15:42:51














»Ø¸´´ËÂ¥